[go: up one dir, main page]

TN2015000176A1 - Pastille medicamenteuse a base d'ibuprofene sodique dihydrate - Google Patents

Pastille medicamenteuse a base d'ibuprofene sodique dihydrate

Info

Publication number
TN2015000176A1
TN2015000176A1 TNP2015000176A TN2015000176A TN2015000176A1 TN 2015000176 A1 TN2015000176 A1 TN 2015000176A1 TN P2015000176 A TNP2015000176 A TN P2015000176A TN 2015000176 A TN2015000176 A TN 2015000176A TN 2015000176 A1 TN2015000176 A1 TN 2015000176A1
Authority
TN
Tunisia
Prior art keywords
drug
pastille
sodium dihydrate
ibuprofen sodium
dihydrate
Prior art date
Application number
TNP2015000176A
Other languages
English (en)
Inventor
Jean-François Cordoliani
Nadine Harambillet
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48050846&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TN2015000176(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of TN2015000176A1 publication Critical patent/TN2015000176A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention a pour objet des pastilles médicamenteuses à sucer, de consistance solide pour se dissoudre dans la cavité buccale comprenant au moins l'ibuprofène sodique dihydraté comme principe actif, destinées au traitement des affections bucco-pharyngées.
TNP2015000176A 2012-11-14 2015-05-07 Pastille medicamenteuse a base d'ibuprofene sodique dihydrate TN2015000176A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1260815A FR2997856B1 (fr) 2012-11-14 2012-11-14 Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
PCT/EP2013/073868 WO2014076203A1 (fr) 2012-11-14 2013-11-14 Pastille medicamenteuse a base d'ibuprofene sodique dihydrate

Publications (1)

Publication Number Publication Date
TN2015000176A1 true TN2015000176A1 (fr) 2016-10-03

Family

ID=48050846

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2015000176A TN2015000176A1 (fr) 2012-11-14 2015-05-07 Pastille medicamenteuse a base d'ibuprofene sodique dihydrate

Country Status (17)

Country Link
US (1) US20160287514A1 (fr)
EP (1) EP2919752A1 (fr)
JP (1) JP6258342B2 (fr)
KR (1) KR20150084919A (fr)
CN (1) CN104780907A (fr)
AP (1) AP2015008515A0 (fr)
AU (1) AU2013346775B2 (fr)
BR (1) BR112015010808A2 (fr)
CA (1) CA2890832A1 (fr)
CL (1) CL2015001308A1 (fr)
FR (1) FR2997856B1 (fr)
MA (1) MA38162B1 (fr)
MX (1) MX2015006011A (fr)
RU (1) RU2015122217A (fr)
TN (1) TN2015000176A1 (fr)
WO (1) WO2014076203A1 (fr)
ZA (1) ZA201504280B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7214331B2 (ja) * 2016-12-28 2023-01-30 小林製薬株式会社 医薬組成物
US11413257B2 (en) * 2017-11-27 2022-08-16 Lodaat Pharmaceuticals Methods for preparing curcuminoid compositions
MX2022002169A (es) * 2019-08-22 2022-03-22 Applied Biological Laboratories Inc Composiciones y metodos que utilizan farmacos antiinflamatorios no esteroideos.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992020334A1 (fr) * 1991-05-13 1992-11-26 The Boots Company Plc Composition pharmaceutique comprenant un sel d'ibuprofene
GB9710521D0 (en) * 1997-05-22 1997-07-16 Boots Co Plc Process
CH693586A8 (de) * 2002-10-14 2003-12-15 Roche Consumer Health Ag Darreichungsform von Ibuprofen-Natrium.
FR2865648B1 (fr) 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
GB2429916A (en) * 2004-06-07 2007-03-14 Strides Arcolab Ltd Pharmaceutical composition containing a stable and clear solution of anti-inflammatory drug in soft gelatin capsule and process for producing the same
KR101482922B1 (ko) * 2004-08-12 2015-01-15 레킷트 벵키저 헬스케어(유케이)리미티드 용융 압출에 의해 제조된, ｎｓａｉｄ와 당 알콜을 포함하는 과립
GB2423710A (en) * 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
AU2006312119B2 (en) * 2005-11-02 2010-04-29 Teikoku Pharma Usa, Inc. Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same
JP2009538359A (ja) * 2006-05-26 2009-11-05 オースペックス・ファーマシューティカルズ・インコーポレイテッド 置換カルボン酸化合物の製造および利用
CN102557918B (zh) * 2011-11-28 2013-08-21 海南永田药物研究院有限公司 一种布洛芬钠化合物及其制法

Also Published As

Publication number Publication date
BR112015010808A2 (pt) 2017-07-11
AU2013346775B2 (en) 2018-06-28
EP2919752A1 (fr) 2015-09-23
WO2014076203A1 (fr) 2014-05-22
KR20150084919A (ko) 2015-07-22
AP2015008515A0 (en) 2015-06-30
RU2015122217A (ru) 2017-01-10
CN104780907A (zh) 2015-07-15
ZA201504280B (en) 2017-09-27
JP2015537019A (ja) 2015-12-24
MA38162A1 (fr) 2016-12-30
AU2013346775A1 (en) 2015-07-02
FR2997856A1 (fr) 2014-05-16
CL2015001308A1 (es) 2015-08-28
FR2997856B1 (fr) 2015-04-24
MA38162B1 (fr) 2019-12-31
MX2015006011A (es) 2015-09-10
JP6258342B2 (ja) 2018-01-10
US20160287514A1 (en) 2016-10-06
CA2890832A1 (fr) 2014-05-22

Similar Documents

Publication Publication Date Title
CY1123549T1 (el) Σταθερη φαρμακευτικη συνθεση και μεθοδοι χρησης αυτης
EP2868667A4 (fr) Agent thérapeutique à base d'anticorps anti-bmp9 en tant que principe actif, pour le traitement de l'anémie, notamment une anémie rénale et une anémie liée à un cancer
EA201071144A1 (ru) Гетероциклические производные
EP2418945A4 (fr) Compositions de sel minéral/acide sulfonique et procédés d'utilisation
EA201200551A1 (ru) Фармацевтическая композиция, фармацевтическая дозированная форма, способы их получения и применения для лечения
EA201270216A1 (ru) Фармацевтический состав
EP2279003A4 (fr) Anticorps anti-cd137 en tant qu'agent dans le traitement d'états inflammatoires
TR201903492T4 (tr) Apomorfin ve organik asitler içeren bileşimler ve bunların kullanım alanları.
EA201201665A1 (ru) Новые соединения
EP3003285A4 (fr) Forme dosifiée pharmaceutique solide de libération d'au moins un principe pharmaceutique actif dans la cavité buccale
MX2011007192A (es) Composicion farmaceutica.
MA38349A1 (fr) Œstra-1,3,5(10),16-tétraéno-3-carboxamide pour inhiber la 17-bêta-hydroxystéroïde déshydrogénase (akr1c3)
EA201690854A1 (ru) Фармацевтические композиции с гидратирующим и смазывающим действием
EP2468771A4 (fr) Composition pharmaceutique contenant un anticorps anti-hb-egf comme ingrédient actif
EA201500245A1 (ru) Твердый фармацевтический препарат, который содержит левотироксин
EA201690005A1 (ru) Состав с модифицированной кинетикой высвобождения
FR2915683B1 (fr) Formulations pharmaceutiques auto-precipitantes pour la liberation modifiee de principe actif
DOP2011000335A (es) Combinacion antitumoral que comprende ave8062 y sorafenib
MA34946B1 (fr) Nouvelles benzodioxolepipérazines
TN2015000176A1 (fr) Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
MA35457B1 (fr) Nouvelles formulations de pyriméthanil et leur utilisations dans le traitement des cultures
EA201100287A1 (ru) Композиция ропинирола
EP2865380A4 (fr) Application de lactone a d'inula linariifolia dans une préparation de médicament destiné au traitement de la myocardite
EA201270653A1 (ru) Антагонист dpи его применение
ECSP15030460A (es) Composición de difenidol de liberación prolongada